Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Garcia de la Calle LE"'
Autor:
Ramon-Patino JL; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain., Ruz-Caracuel I; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain., Heredia-Soto V; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain., Garcia de la Calle LE; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain., Zagidullin B; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Wang Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Berjon A; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Lopez-Janeiro A; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain., Miguel M; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Escudero J; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Gallego A; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain., Castelo B; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Cátedra UAM-ANGEM, Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain., Yebenes L; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain., Hernandez A; Department of Obstetrics & Gynaecology, Hospital Universitario La Paz, IdiPAZ, 28046 Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain., Feliu J; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Cátedra UAM-ANGEM, Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain., Pelaez-García A; Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland., Hardisson D; Department of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain., Mendiola M; Center for Biomedical Research in the Cancer Network (Centro de Investigación Biomédica en Red de Cáncer, CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Molecular Pathology and Therapeutic Targets Group, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Redondo A; Department of Medical Oncology, Hospital Universitario La Paz, 28046 Madrid, Spain.; Translational Oncology Research Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.; Cátedra UAM-ANGEM, Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 12; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 12.
Autor:
Mendiola M; Molecular Pathology and Therapeutic Targets Group, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain. marta.mendiola@salud.madrid.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. marta.mendiola@salud.madrid.org., Pellinen T; Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland., Ramon-Patino JL; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario Rey Juan Carlos, 28933, Móstoles, Madrid, Spain., Berjon A; Department of Pathology, Hospital Universitario La Paz, Madrid, Spain., Bruck O; Hematology Research Unit Helsinki, University of Helsinki and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland., Heredia-Soto V; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Translational Oncology Research Laboratory, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain., Turkki R; Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.; AstraZeneca, Gothenburg, Sweden., Escudero J; Translational Oncology Research Laboratory, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain., Hemmes A; Institute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland., Garcia de la Calle LE; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain., Crespo R; Translational Oncology Research Laboratory, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain., Gallego A; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.; Translational Oncology Research Laboratory, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain., Hernandez A; Department of Gynecology, Hospital Universitario La Paz, Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain., Feliu J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain.; Translational Oncology Research Laboratory, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Cátedra UAM-ANGEM, Universidad Autónoma de Madrid, Madrid, Spain., Redondo A; Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. andres.redondos@uam.es.; Translational Oncology Research Laboratory, Instituto de Investigación Biomédica del Hospital La Paz (IdiPAZ), Madrid, Spain. andres.redondos@uam.es.; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. andres.redondos@uam.es.; Cátedra UAM-ANGEM, Universidad Autónoma de Madrid, Madrid, Spain. andres.redondos@uam.es.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Feb; Vol. 35 (2), pp. 256-265. Date of Electronic Publication: 2021 Oct 12.